The Center for Pharmaceutical Research Report issue

Academic/Hospital Phase 1 Phase 2
Status: Acquired by Alliance for Multispecialty Research (2017)

Organization Overview

First Clinical Trial
2008
NCT00754455
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

The Center for Pharmaceutical Research

Active Ingredients

Drugs in Phase 2 Trials (1)

influenza vlp vaccine (1 trial)

Drugs in Phase 1 Trials (2)

crv 101 (1 trial)

medi7510 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Herpes Zoster (Phase 1)

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3